ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer
Abstract Small cell lung cancer (SCLC) is characterized by its highly aggressive phenotype and dismal outcome. Despite the benefit of adding immune checkpoint blockade to standa...